CD8A and infection: Interestingly, SVPs may alter in vitro infection in a dose-dependent manner [8,9,10], and while the influence of these SVPs on HBV infection is not completely understood in vivo, there is evidence that they affect the outcome of infection by binding neutralizing antibodies and preventing CD8 T cell responses [11].